Synendos Therapeutics
Synendos Therapeutics is a biopharmaceutical company developing a new class of small molecules aimed at restoring the natural balance of the endocannabinoid system. Their lead drug candidates focus on treating central nervous system disorders, specifically targeting anxiety and stress-related conditions through a novel mechanism of action.
Biotechnology
Pharmaceuticals
Healthtech
Funding summary
- Total raised
- €18.5M
- Funding rounds
- 1
Investors in Synendos Therapeutics
Investors on record for Synendos Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Synendos Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors